スポンサーリンク
Department Of Hematology Nagoya Daini Red Cross Hospital | 論文
- Posttreatment M-Protein Nadir Level Is a Significant Prognostic Factor Associated with Survival in Multiple Myeloma
- Analysis of 55 Transplantations from Unrelated Volunteer Donors Facilitated by Tokai Marrow Donor Bank
- Severe Hypercholesterolemia Associated with Decreased Hepatic Triglyceride Lipase Activity and Pseudohyponatremia in Patients after Allogeneic Stem Cell Transplantation
- Relationship between dietary habits and urinary concentrations of 3-phenoxybonzoic acid in a middle-aged and elderly general population in Japan
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
- Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- L-myc Genotype is Associated with Different Susceptibility to Lung Cancer in Smokers
- Different Susceptibility of Each L-myc Genotype to Esophageal Cancer Risk Factors
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
- Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer
- Association of serum carotenoids, retinol, and tocopherols with radiographic knee osteoarthritis : possible risk factors in rural Japanese inhabitants
- Association of serum NO_x level with clustering of metabolic syndrome components in middle-aged and elderly general populations in Japan
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
- WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
- Successful Treatment of Tacrolimus (FK506)-Related Leukoencephalopathy with Cerebral Hemorrhage in a Patient Who Underwent Nonmyeloablative Stem Cell Transplantation
- WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
- Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis